Lifshitz & Miller Law Firm Announces Investigation of Electronics for Imaging, Inc., Ferrellgas Partners LP, Fusion Pharm, Inc., Humana Inc., KemPharm, Inc., National Beverage Corp., Puma Biotechnology, Inc., and TG Therapeutics, Inc.

NEW YORK, Oct. 31, 2016 /PRNewswire/ --

Electronics for Imaging, Inc. (EFII)

Lifshitz & Miller announces investigation on behalf of EFII investors.  The investigation concerns whether EFII adequately disclosed its earnings, projections and price targets.

If you are an EFII investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Ferrellgas Partners LP (FGP)

Lifshitz & Miller announces investigation on behalf of FGP investors.  The investigation concerns FGP's reporting of poor earnings in its 2015 annual report and that FGP may reduce the annual distribution to shareholders by more than half.

If you are an FGP investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Fusion Pharm, Inc. (FSPM)

Lifshitz & Miller announces investigation on behalf of Fusion investors.  The investigation concerns whether Fusion inflated FSPM's revenues for purported sales of PharmPods.

If you are a FSPM investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Humana Inc. (HUM)

Lifshitz & Miller announces investigation on behalf of Humana investors.  The investigation concerns whether Humana adequately disclosed Humana's membership percentage in plans rated four stars or higher.

If you are a Humana investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

KemPharm, Inc. (KMPH)

Lifshitz & Miller announces investigation on behalf of KMPH investors.  The investigation concerns whether KMPH adequately disclosed material information about Apadaz.

If you are a KMPH investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

National Beverage Corp. (FIZZ)

Lifshitz & Miller announces investigation on behalf of FIZZ investors.  The investigation concerns a report by Glaucus Research, which alleged that FIZZ's former CEO manipulated earnings, refused to provide adequate due diligence for a potential acquirer, and that insiders are compensated from a private corporation, outside of shareholder visibility.

If you are an FIZZ investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Puma Biotechnology, Inc. (PBYI)

Lifshitz & Miller announces investigation on behalf of Puma investors.  The investigation concerns whether Puma adequately disclosed the efficacy for Puma's drug candidate Neratinib.

If you are a Puma investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

TG Therapeutics, Inc. (TGTX)

Lifshitz & Miller announces investigation on behalf of TGTX investors.  The investigation concerns whether TGTX adequately disclosed TGTX's GENUINE study.

For additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING. © 2016 Lifshitz & Miller.  The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone:  516-493-9780 
Facsimile: 516-280-7376
Email: [email protected]

SOURCE Lifshitz & Miller Law Firm

Related Links

http://jlclasslaw.com